Effects of Weight Loss Surgery on Bone Health in Adolescents

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

240 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-06-01

Study Completion Date

2027-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to examine the impact of weight-loss surgery (Roux-en-Y gastric bypass or Vertical Sleeve Gastrectomy) on bone outcomes in girls and boys ages 13-21. This study will also examine a group of overweight boys and girls who are not scheduled or planned for surgery for comparison of these outcomes.

Obese adults who undergo weight-loss surgery are at risk for bone loss and decreased bone strength. The investigators do not know the effects of such surgery on bone in teenagers and young adults. The purpose of this study is to find out how different types of weight loss surgery affect bone density and strength in teenagers and young adults and compare these results to obese teenagers and young adults who are not undergoing weight-loss surgery.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Clinical-functional Effects of Bariatric Surgery on the Musculoskeletal System in Relation to Bone Turnover.

NCT06299085

Bariatric Surgery Candidate

NOT_YET_RECRUITING NA

Bariatric Surgery and Skeletal Health

NCT01098942

Morbid Obesity

COMPLETED

Skeletal Health in Bariatric Surgery Patients

NCT03331536

Bariatric Surgery Osteoporosis Fractures, Bone +4 more

COMPLETED

Bone Metabolism After Bariatric Surgery

NCT01824797

Obesity Osteoporosis

COMPLETED

Weight Loss Surgery in Adolescents With Extreme Obesity

NCT02062164

Obesity Extreme Obesity

ACTIVE_NOT_RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Our overall hypothesis is that both Roux-en-Y Gastric Bypass (RYGB) and vertical sleeve gastrectomy (VSG) in adolescents with morbid obesity will lead to a reduction in areal and volumetric BMD, and deterioration in bone structure and estimated bone strength, and an increase in marrow adiposity. We further hypothesize that these effects will be due in part to a decrease in lean mass, changes in enteric peptide hormones and reduced estrogen levels.

We will enroll 120 participants 13-21 years old for this two-year longitudinal study (36 in each of the surgical groups and 48 non-surgical controls with obesity). We will screen up to 240 subjects to find these 120 eligibile subjects. Areal bone mineral density (BMD) will be assessed by dual energy x-ray absorptiometry (DXA), volumetric BMD by quantitative computed tomography (QCT), bone structure and strength using high resolution peripheral QCT and finite element analysis, and marrow fat using magnetic resonance spectroscopy. Body composition will also be assessed.

Adolescence is a critical time for bone accrual and the use of bariatric procedures is increasing in teenagers. This study will provide novel data needed to establish effects of RYGB vs. VSG on bone in adolescents and will begin to delineate underlying mechanisms. Clarifying these mechanisms will identify therapeutic targets to optimize bone accrual in adolescents undergoing bariatric surgery.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obesity Surgery

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Roux-en-Y Gastric Bypass

Males and females aged 13-25 undergoing Roux-en-Y gastric bypass (RYGB) surgery

Roux-en-Y Gastric Bypass

Intervention Type PROCEDURE

Determination of the kind of surgery will be made by the participant's providers and not by study staff

Vertical Sleeve Gastrectomy

Males and females aged 13-25 undergoing vertical sleeve gastrectomy (VSG) surgery

Vertical Sleeve Gastrectomy

Intervention Type PROCEDURE

Determination of the kind of surgery will be made by the participant's providers and not by study staff

Non-surgical Obese Controls

Males and females aged 13-25 who are obese and not undergoing weight loss surgery

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Roux-en-Y Gastric Bypass

Determination of the kind of surgery will be made by the participant's providers and not by study staff

Intervention Type PROCEDURE

Vertical Sleeve Gastrectomy

Determination of the kind of surgery will be made by the participant's providers and not by study staff

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

RYGB VSG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Adolescents with morbid obesity 13-25yo undergoing RYGB (n=36) or VSG (n=36), or being followed without surgical intervention (usual care) (n=48).
2. Eligibility criteria for weight loss surgery used at the Weight Center include BMI\>40 or BMI\>35kg/m2 with major comorbidities. A BMI\>35 in adolescents reflects a BMI\>99th percentile. In order to be considered appropriate surgical candidates, children must have a bone age of ≥14y (F) or ≥16y (M), and ≥1 co-morbidity of obesity. They must have demonstrated efforts at non-surgical weight loss, and consistent compliance with appointments and recommendations. Patients must demonstrate sufficient maturity, psychological stability and cognitive capacity to recognize the significance of the procedure and implement required post-operative behavioral changes.

Exclusion Criteria

1. Current pregnancy and breast feeding
2. Medications other than calcium or vitamin D that affect bone, such as glucocorticoids, phenytoin, phenobarbitone (washout of 3 months prior to enrollment if discontinuation is medically permissible)
3. Use of antipsychotic medications that cause weight gain if treated for \<6 mos, or if dosage is not stable for \>2 mos
4. Untreated thyroid dysfunction or on stable dose for \<3 mos
5. HbA1C\>8% (to avoid deleterious effects on bone from uncontrolled T2DM)
6. Smoking \>10 cigarettes/day; substance abuse per Diagnostic and Statistical Manual (DSM) V
7. Metal implants, intracranial surgical clips or pacemakers
8. Weight \>450 lbs due to limits for MRI and CT.

Minimum Eligible Age

13 Years

Maximum Eligible Age

25 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No